Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Food-Grade Saponin Extract as an Emulsifier and Immunostimulant in Emulsion-Based Subunit Vaccine for Pigs.

Burakova Y, Madera R, Wang L, Buist S, Lleellish K, Schlup JR, Shi J.

J Immunol Res. 2018 Nov 27;2018:8979838. doi: 10.1155/2018/8979838. eCollection 2018.

2.

Plant-made E2 glycoprotein single-dose vaccine protects pigs against classical swine fever.

Laughlin RC, Madera R, Peres Y, Berquist BR, Wang L, Buist S, Burakova Y, Palle S, Chung CJ, Rasmussen MV, Martel E, Brake DA, Neilan JG, Lawhon SD, Adams LG, Shi J, Marcel S.

Plant Biotechnol J. 2019 Feb;17(2):410-420. doi: 10.1111/pbi.12986. Epub 2018 Aug 10.

3.

Toward the development of a one-dose classical swine fever subunit vaccine: antigen titration, immunity onset, and duration of immunity.

Madera RF, Wang L, Gong W, Burakova Y, Buist S, Nietfeld J, Henningson J, Cino-Ozuna AG, Tu C, Shi J.

J Vet Sci. 2018 May 31;19(3):393-405. doi: 10.4142/jvs.2018.19.3.393.

4.

Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study.

Horner A, Soriano JB, Puhan MA, Studnicka M, Kaiser B, Vanfleteren LEGW, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S, Flamm M, Lamprecht B; BOLD Collaborative Research Group; EPI-SCAN Team; PLATINO Team; PREPOCOL Study Group.

Respir Res. 2017 Aug 23;18(1):162. doi: 10.1186/s12931-017-0643-5.

5.

The association between chronic airflow obstruction and poverty in 12 sites of the multinational BOLD study.

Townend J, Minelli C, Mortimer K, Obaseki DO, Al Ghobain M, Cherkaski H, Denguezli M, Gunesekera K, Hafizi H, Koul PA, Loh LC, Nejjari C, Patel J, Sooronbayev T, Buist SA, Burney PGJ.

Eur Respir J. 2017 Jun 1;49(6). pii: 1601880. doi: 10.1183/13993003.01880-2016. Print 2017 Jun.

6.

Long-Term Healthcare Outcomes of Preterm Birth: An Executive Summary of a Conference Sponsored by the National Institutes of Health.

Raju TNK, Pemberton VL, Saigal S, Blaisdell CJ, Moxey-Mims M, Buist S; Adults Born Preterm Conference Speakers and Discussants.

J Pediatr. 2017 Feb;181:309-318.e1. doi: 10.1016/j.jpeds.2016.10.015. Epub 2016 Oct 31. No abstract available.

PMID:
27806833
7.

Raising the Profile of Pulmonary Education for Physicians in Low- and Middle-Income Countries.

Obaseki DO, Lugogo NL, Buist SA.

Ann Am Thorac Soc. 2016 Apr;13(4):458-9. doi: 10.1513/AnnalsATS.201601-085ED. No abstract available.

PMID:
27058181
8.

Lung function defects in treated pulmonary tuberculosis patients.

Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, Gislason T, Mannino D, Bateman ED, Buist S, Burney PG; BOLD Collaborative Research Group.

Eur Respir J. 2016 Jan;47(1):352-3. doi: 10.1183/13993003.01366-2015. No abstract available.

9.

Burden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary disease.

Sharifi H, Masjedi MR, Emami H, Ghanei M, Eslaminejad A, Radmand G, Buist S.

Lung India. 2015 Nov-Dec;32(6):572-7. doi: 10.4103/0970-2113.168129.

10.

Chronic Airflow Obstruction in a Black African Population: Results of BOLD Study, Ile-Ife, Nigeria.

Obaseki DO, Erhabor GE, Gnatiuc L, Adewole OO, Buist SA, Burney PG.

COPD. 2016;13(1):42-9. doi: 10.3109/15412555.2015.1041102. Epub 2015 Oct 9.

11.

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results.

Amaral AF, Coton S, Kato B, Tan WC, Studnicka M, Janson C, Gislason T, Mannino D, Bateman ED, Buist S, Burney PG; BOLD Collaborative Research Group.

Eur Respir J. 2015 Oct;46(4):1104-12. doi: 10.1183/13993003.02325-2014. Epub 2015 Jun 25.

12.

Determinants of underdiagnosis of COPD in national and international surveys.

Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S; BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group.

Chest. 2015 Oct;148(4):971-985. doi: 10.1378/chest.14-2535.

PMID:
25950276
13.

Burden of obstructive lung disease study in tehran: research design and lung spirometry protocol.

Sharifi H, Masjedi MR, Emami H, Ghanei M, Buist S.

Int J Prev Med. 2014 Nov;5(11):1439-45.

14.

Symptomatic chronic obstructive pulmonary disease in clinical trials and in a population-based study.

Niederseer D, Richter SA, Neunhäuserer D, Lamprecht B, Buist SA, Studnicka M, Niebauer J.

Sleep Breath. 2015 Sep;19(3):801-8. doi: 10.1007/s11325-014-1087-5. Epub 2014 Nov 27.

PMID:
25427819
16.

Respiratory risks from household air pollution in low and middle income countries.

Gordon SB, Bruce NG, Grigg J, Hibberd PL, Kurmi OP, Lam KB, Mortimer K, Asante KP, Balakrishnan K, Balmes J, Bar-Zeev N, Bates MN, Breysse PN, Buist S, Chen Z, Havens D, Jack D, Jindal S, Kan H, Mehta S, Moschovis P, Naeher L, Patel A, Perez-Padilla R, Pope D, Rylance J, Semple S, Martin WJ 2nd.

Lancet Respir Med. 2014 Oct;2(10):823-60. doi: 10.1016/S2213-2600(14)70168-7. Epub 2014 Sep 2. Review.

17.

Exacerbations in non-COPD patients: truth or myth--authors' response.

Tan WC, Bourbeau J, Aaron S, FitzGerald JM, Hernandez P, Cowie R, Chapman KR, Marciniuk D, Maltais F, Buist S, O'Donnell D, Sin DD; CanCOLD Collaborative Research Group.

Thorax. 2014 Nov;69(11):1050-1. doi: 10.1136/thoraxjnl-2014-205889. Epub 2014 Jul 4. No abstract available.

PMID:
24996635
18.

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty: a BOLD analysis--authors' reply.

Burney P, Kato B, Janson C, Mannino D, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study.

Thorax. 2014 Sep;69(9):869-70. doi: 10.1136/thoraxjnl-2014-205474. Epub 2014 May 1. No abstract available.

PMID:
24789424
19.

Medical students' knowledge about the management of chronic obstructive pulmonary disease in Nigeria.

Ozoh OB, Awokola T, Buist SA.

Int J Tuberc Lung Dis. 2014 Jan;18(1):117-21. doi: 10.5588/ijtld.13.0453.

PMID:
24365563
20.

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis.

Burney P, Jithoo A, Kato B, Janson C, Mannino D, Nizankowska-Mogilnicka E, Studnicka M, Tan W, Bateman E, Koçabas A, Vollmer WM, Gislason T, Marks G, Koul PA, Harrabi I, Gnatiuc L, Buist S; Burden of Obstructive Lung Disease (BOLD) Study.

Thorax. 2014 May;69(5):465-73. doi: 10.1136/thoraxjnl-2013-204460. Epub 2013 Dec 18.

21.

Prevalence of COPD and tobacco smoking in Tunisia--results from the BOLD study.

Daldoul H, Denguezli M, Jithoo A, Gnatiuc L, Buist S, Burney P, Tabka Z, Harrabi I.

Int J Environ Res Public Health. 2013 Dec 17;10(12):7257-71. doi: 10.3390/ijerph10127257.

22.

The impact of COPD on health status: findings from the BOLD study.

Janson C, Marks G, Buist S, Gnatiuc L, Gislason T, McBurnie MA, Nielsen R, Studnicka M, Toelle B, Benediktsdottir B, Burney P.

Eur Respir J. 2013 Dec;42(6):1472-83. doi: 10.1183/09031936.00153712. Epub 2013 May 30.

23.

Can spirometric norms be set using pre- or post- bronchodilator test results in older people?

Kato B, Gulsvik A, Vollmer W, Janson C, Studnika M, Buist S, Burney P.

Respir Res. 2012 Nov 16;13:102. doi: 10.1186/1465-9921-13-102.

24.

Simple and rapid determination of norethindrone in human plasma by supported liquid extraction and ultra performance liquid chromatography with tandem mass spectrometry.

Gong Z, Chandler K, Webster S, Kerley R, Buist S, McCort-Tipton M.

Talanta. 2012 Mar 15;91:77-82. doi: 10.1016/j.talanta.2012.01.019. Epub 2012 Jan 14.

PMID:
22365683
25.

Can age and sex explain the variation in COPD rates across large urban cities? A population study in Canada.

Tan WC, Bourbeau J, FitzGerald JM, Cowie R, Chapman K, Hernandez P, Buist SA, Sin DD.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1691-8. doi: 10.5588/ijtld.11.0211.

PMID:
22118181
26.

Pre- and post-bronchodilator lung function as predictors of mortality in the Lung Health Study.

Mannino DM, Diaz-Guzman E, Buist S.

Respir Res. 2011 Oct 12;12:136. doi: 10.1186/1465-9921-12-136.

27.

Evaluation of pharmacokinetic/pharmacodynamic relationships of PD-0162819, a biotin carboxylase inhibitor representing a new class of antibacterial compounds, using in vitro infection models.

Ogden A, Kuhn M, Dority M, Buist S, Mehrens S, Zhu T, Xiao D, Miller JR, Hanna D.

Antimicrob Agents Chemother. 2012 Jan;56(1):124-9. doi: 10.1128/AAC.00090-11. Epub 2011 Oct 10.

28.

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population.

Fletcher MJ, Upton J, Taylor-Fishwick J, Buist SA, Jenkins C, Hutton J, Barnes N, Van Der Molen T, Walsh JW, Jones P, Walker S.

BMC Public Health. 2011 Aug 1;11:612. doi: 10.1186/1471-2458-11-612.

29.

Subjects with Discordant Airways Obstruction: Lost between Spirometric Definitions of COPD.

Lamprecht B, Schirnhofer L, Kaiser B, Buist SA, Mannino DM, Studnicka M.

Pulm Med. 2011;2011:780215. doi: 10.1155/2011/780215. Epub 2011 Feb 6.

30.

COPD in never smokers: results from the population-based burden of obstructive lung disease study.

Lamprecht B, McBurnie MA, Vollmer WM, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E, Studnicka M, Bateman E, Anto JM, Burney P, Mannino DM, Buist SA; BOLD Collaborative Research Group.

Chest. 2011 Apr;139(4):752-763. doi: 10.1378/chest.10-1253. Epub 2010 Sep 30.

31.

Marijuana and chronic obstructive lung disease: a population-based study.

Tan WC, Lo C, Jong A, Xing L, Fitzgerald MJ, Vollmer WM, Buist SA, Sin DD; Vancouver Burden of Obstructive Lung Disease (BOLD) Research Group.

CMAJ. 2009 Apr 14;180(8):814-20. doi: 10.1503/cmaj.081040.

32.

A class of selective antibacterials derived from a protein kinase inhibitor pharmacophore.

Miller JR, Dunham S, Mochalkin I, Banotai C, Bowman M, Buist S, Dunkle B, Hanna D, Harwood HJ, Huband MD, Karnovsky A, Kuhn M, Limberakis C, Liu JY, Mehrens S, Mueller WT, Narasimhan L, Ogden A, Ohren J, Prasad JV, Shelly JA, Skerlos L, Sulavik M, Thomas VH, VanderRoest S, Wang L, Wang Z, Whitton A, Zhu T, Stover CK.

Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1737-42. doi: 10.1073/pnas.0811275106. Epub 2009 Jan 22.

33.

A vision statement on guideline development for respiratory disease: the example of COPD.

Schünemann HJ, Woodhead M, Anzueto A, Buist S, Macnee W, Rabe KF, Heffner J.

Lancet. 2009 Feb 28;373(9665):774-9. doi: 10.1016/S0140-6736(08)61347-1. Epub 2008 Oct 3. No abstract available.

PMID:
18835641
34.

Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study.

Lamprecht B, Schirnhofer L, Kaiser B, Buist S, Studnicka M.

Respir Med. 2008 Dec;102(12):1833-8. doi: 10.1016/j.rmed.2008.07.007. Epub 2008 Aug 22.

35.

Validation of a rat in vivo [(3)H]M100907 binding assay to determine a translatable measure of 5-HT(2A) receptor occupancy.

Knauer CS, Campbell JE, Galvan B, Bowman C, Osgood S, Buist S, Buchholz L, Henry B, Wong EH, Shahid M, Grimwood S.

Eur J Pharmacol. 2008 Sep 4;591(1-3):136-41. doi: 10.1016/j.ejphar.2008.06.063. Epub 2008 Jun 19.

PMID:
18593577
36.

Gender and chronic obstructive pulmonary disease: why it matters.

Han MK, Postma D, Mannino DM, Giardino ND, Buist S, Curtis JL, Martinez FJ.

Am J Respir Crit Care Med. 2007 Dec 15;176(12):1179-84. Epub 2007 Aug 2.

37.

Six-second spirometry for detection of airway obstruction: a population-based study in Austria.

Lamprecht B, Schirnhofer L, Tiefenbacher F, Kaiser B, Buist SA, Studnicka M, Enright P.

Am J Respir Crit Care Med. 2007 Sep 1;176(5):460-4. Epub 2007 Jun 7.

PMID:
17556719
38.

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.

Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease.

Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. Epub 2007 May 16. Review.

PMID:
17507545
39.

Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease.

Machado MC, Krishnan JA, Buist SA, Bilderback AL, Fazolo GP, Santarosa MG, Queiroga F Jr, Vollmer WM.

Am J Respir Crit Care Med. 2006 Sep 1;174(5):524-9. Epub 2006 Jun 15.

PMID:
16778158
40.

International Primary Care Respiratory Group (IPCRG) Guidelines: management of chronic obstructive pulmonary disease (COPD).

Bellamy D, Bouchard J, Henrichsen S, Johansson G, Langhammer A, Reid J, van Weel C, Buist S.

Prim Care Respir J. 2006 Feb;15(1):48-57. Epub 2006 Jan 18.

41.

COPD: a common disease that is preventable and treatable.

Buist S.

Prim Care Respir J. 2006 Feb;15(1):7-9. Epub 2006 Jan 18. No abstract available.

42.

Chronic obstructive pulmonary disease: current burden and future projections.

Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, Schmid V, Buist S.

Eur Respir J. 2006 Feb;27(2):397-412. No abstract available.

43.
44.

Endocrine regulation of rat organic anion transporters.

Buist SC, Cherrington NJ, Klaassen CD.

Drug Metab Dispos. 2003 May;31(5):559-64.

PMID:
12695343
45.

Tissue distribution and chemical induction of multiple drug resistance genes in rats.

Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, Klaassen CD.

Drug Metab Dispos. 2002 Jul;30(7):838-44.

PMID:
12065443
46.

Gender-specific and developmental influences on the expression of rat organic anion transporters.

Buist SC, Cherrington NJ, Choudhuri S, Hartley DP, Klaassen CD.

J Pharmacol Exp Ther. 2002 Apr;301(1):145-51.

PMID:
11907168
47.

Smoking cessation in patients with chronic obstructive pulmonary disease: a double-blind, placebo-controlled, randomised trial.

Tashkin D, Kanner R, Bailey W, Buist S, Anderson P, Nides M, Gonzales D, Dozier G, Patel MK, Jamerson B.

Lancet. 2001 May 19;357(9268):1571-5.

PMID:
11377644
48.

The message from the World Asthma Meeting. The Working Groups of the World Asthma Meeting, held in Barcelona, Spain, December 9-13, 1998.

Sterk PJ, Buist SA, Woolcock AJ, Marks GB, Platts-Mills TA, von Mutius E, Bousquet J, Frew AJ, Pauwels RA, Aït-Khaled N, Hill SL, Partridge MR.

Eur Respir J. 1999 Dec;14(6):1435-53. Review.

49.

Supplemental Content

Support Center